References
  1. Singh JP, Evans JC, Levy D, Larson MG, Freed LA, Fuller DL, et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 1999;83:897-902.
  2. Stuge O, Liddicoat J. Emerging opportunities for cardiac surgeons within structural heart disease. J Thorac Cardiovasc Surg 2006;132:1258-61.
  3. Badano LP, Muraru D, Enriquez-Sarano M. Assessment of functional tricuspid regurgitation. Eur Heart J 2013;34:1875-85.
  4. Stephens EH, Borger MA. ”Forgotten” valve or ”enigmatic” valve? Further insights into the tricuspid valve in patients undergoing mitral valve surgery. J Thorac Cardiovasc Surg 2014; 148:1962-1964.
  5. Lentini S. Surgery for rheumatic mitral valve disease and the forgotten role of concomitant organic tricuspid valve impairment. Heart 2013; 99:145.
  6. Braunwald NS, Ross J Jr, Morrow AG. Conservative management of tricuspid regurgitation in patients undergoing mitral valve replacement. Circulation 1967; 35(4, Suppl): I63–I69.
  7. Zack CJ, Fender EA, Chandrashekar P, Reddy YNV, Bennett CE, Stulak JM, et al. National trends and outcomes in isolated tricuspid valve surgery. J Am Coll Cardiol 2017; 70:2953–60.
  8. Tagliari AP, Taramasso M. Transcatheter tricuspid interventions: time to re-think guidelines? Aging (Albany NY) 2020; 12:1037-1038.
  9. Katsi V, Raftopoulos L, Aggeli C, Vlasseros I, Felekos I, Tousoulis D, et al. Tricuspid regurgitation after successful mitral valve surgery. Interact Cardiovasc Thorac Surg 2012; 15:102-8.
  10. Dreyfus GD, Corbi PJ, Chan KM, Bahrami T. Secondary tricuspid regurgitation or dilatation: Which should be the criteria for surgical repair? Ann Thorac Surg 2005; 79:127-32.
  11. Kilic A, Saha-Chaudhuri P, Rankin JS, Conte JV. Trends and outcomes of tricuspid valve surgery in North America: an analysis of more than 50,000 patients from the Society of Thoracic Surgeons database. Ann Thorac Surg 2013; 96:1546–52.
  12. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, et al., ESC Committee for Practice Guidelines (CPG); Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg 2012; 42:S1-44.
  13. Nath J, Foster E, Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 2004; 43:405–409.
  14. Topilsky Y, Nkomo VT, Vatury O, Michelena HI, Letourneau T, Suri RM, et al. Clinical outcome of isolated tricuspid regurgitation. JACC Cardiovasc Imaging 2014; 7:1185–94.
  15. Topilsky Y, Inojosa JM, Benfari G, Vaturi O, Maltais S, Michelena H, et al. Clinical presentation and outcome of tricuspid regurgitation in patients with systolic dysfunction. Eur Heart J 2018; 39:3584–3592.
  16. Carpentier A, Deloche A, Dauptain J, Soyer R, Blondeau P, Piwnica A, et al. A new reconstructive operation for correction of mitral and tricuspid insufficiency. J Thorac Cardiovasc Surg 1971; 61:1-13.
  17. Colombo T, Russo C, Ciliberto GR, Lanfranconi M, Bruschi G, Agati S, et al.Tricuspid regurgitation secondary to mitral valve disease: tricuspid annulus function as guide to tricuspid valve repair. Cardiovasc Surg. 2001; 9:369-77.
  18. Van de Veire NR, Braun J, Delgado V, Versteegh MI, Dion RA, Klautz RJ, et al. Tricuspid annuloplasty prevents right ventricular dilatation and progression of tricuspid regurgitation in patients with tricuspid anular dilatation undergoing mitral valve repair. J Thorac Cardiovasc Surg 2011; 141:1431–9.
  19. Benedetto U, Melina G, Angeloni E, Refice S, Roscitano A, Comito C, et al. Prophylactic tricuspid annuloplasty in patients with dilated tricuspid annulus undergoing mitral valve surgery. J Thorac Cardiovasc Surg 2012; 143:632-8.
  20. Chikwe J, Itagaki S, Anyanwu A, Adams DH. Impact of Concomitant Tricuspid Annuloplasty on Tricuspid Regurgitation, Right Ventricular Function, and Pulmonary Artery Hypertension After Repair of Mitral Valve Prolapse. J Am Coll Cardiol 2015; 65:1931-8.
  21. Falk V, Baumgartner H, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al; ESC Scientific Document Group. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg 2017; 52:616–64.
  22. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP III, Guyton RA, et al; ACC/AHA Task Force Members. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 2014; 129:2440-92.
  23. David TE, David CM, Manlhiot C. Tricuspid annulus diameter does not predict the development of tricuspid regurgitation after mitral valve repair for mitral regurgitation due to degenerative diseases. J Thorac Cardiovasc Surg 2018; 155:2429-36.
  24. Rajbanshi BG, Suri RM, Nkomo VT, Dearani JA, Daly RC, Burkhart HM, et al. Influence of mitral valve repair versus replacement on the development of late functional tricuspid regurgitation. J Thorac Cardiovasc Surg 2014; 148:1957-62.
  25. Ro SK, Kim JB, Jung SH, Choo SJ, Chung CH, Lee JW. Mild-to-moderate functional tricuspid regurgitation in patients undergoing mitral valve surgery. J Thorac Cardiovasc Surg 2013; 146:1092-7.
  26. Zhu TY, Wang JG, Meng X. Does concomitant tricuspid annuloplasty increase perioperative mortality and morbidity when correcting left-sided valve disease? Interact Cardiovasc Thorac Surg 2015; 20:114-8.
  27. Kilic A, Szeto WY, Atluri P, Acker MA, Hargrove WC. Operative Outcomes of Concomitant Minimally Invasive Mitral and Tricuspid Valve Surgery. Innovations (Phila)  2019; 14:412-418.
  28. LaPar DJ, Mulloy DP, Stone ML, Crosby IK, Lau CL, Kron IL, et al. Concomitant tricuspid valve operations affect outcomes after mitral operations: a multiinstitutional, statewide analysis. Ann Thorac Surg 2012; 94:52-7.
  29. Pettinari M, De Kerchove L, Lazam S, Pasquet A, Gerber B, Vanoverschelde JL, et al. Mid-term results of a randomized trial of tricuspid annuloplasty for less-than-severe functional tricuspid regurgitation at the time of mitral valve surgery. Eur J Cardiothorac Surg 2019; 55:851-858.
  30. Cao JY, Wales KM, Zhao DF, Seco M, Celermajer DS, Bannon PG. Repair of Less Than Severe Tricuspid Regurgitation during Left Sided Valve Surgery: A Meta-Analysis, Ann Thorac Surg 2020; 109:950-958.
  31. David TE, David CM, Tsang W, Lafreniere-Roula M, Manlhiot C. Long-Term Results of Mitral Valve Repair for Regurgitation Due to Leaflet Prolapse. J Am Coll Cardiol. 2019; 74:1044-1053.
  32. Voigtländer L, Seiffert M. Expanding TAVI to Low and Intermediate Risk Patients. Front Cardiovasc Med 2018; 5:92.
  33. Curio J, Demir OM, Pagnesi M, Mangieri A, Giannini F, Weisz G, et al. Update on the Current Landscape of Transcatheter Options for Tricuspid Regurgitation Treatment. Interv Cardiol. 2019; 14:54-61.
  34. Kolte D, Elmariah S. Current state of transcatheter tricuspid valve repair. Cardiovasc Diagn Ther 2020;10:89-97.
  35. Taramasso M, Alessandrini H, Latib A, Asami M, Attinger-Toller A, Biasco L, et al. Outcomes After Current Transcatheter Tricuspid Valve Intervention: Mid-Term Results from the International TriValve Registry. JACC Cardiovasc Interv 2019; 12:155-165.
  36. Taramasso M, Benfari G, van der Bijl P, Alessandrini H, Attinger-TolleA, Biasco L, et al. Transcatheter versus medical treatment of symptomatic severe tricuspid regurgitation.  Am Coll Cardiol 2019; 74:2998-3008.
\sout